Adam’s cross-border practice focuses on corporate law, financing, and technology transactions in the life sciences and health technology industries. His clients include established and emerging life sciences and healthcare companies, as well as the venture capital and private equity funds who finance and partner with them.
Adam has a particular focus on strategic partnering and commercialization for pharmaceutical, biotechnology and medical device companies, frequently advising on complex licensing, strategic collaborations, venture capital, mergers and acquisitions, and intellectual property monetization transactions. He works closely with his clients to develop, scale, and commercialize their technologies in Canada, the U.S. and worldwide.
Adam is qualified as a lawyer in Ontario, New York and Massachusetts and works on both sides of the border. Before law school, Adam attended the Leslie Dan Faculty of Pharmacy at the University of Toronto and is a licensed Ontario pharmacist.
Adam is the chair of the Medical Devices Committee of the Licensing Executives Society (LES) and is one of a handful of Canadian lawyers that have obtained the Certified Licensing Professional (CLP) designation. This certification is issued only to persons who have met the requirements for licensing professionals, established by CLP, Inc., under the guidance of LES.
Adam is a member of the Ontario College of Pharmacists.
In law school, Adam was the coordinator of the IP Osgoode Innovation Clinic and completed a placement in the legal affairs department of a multinational pharmaceutical company.